Search

everythinglearnresearchcommunity

for

Search:↓

Increasing TSPO in the brain may help improve memory problems.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The VMH AMPK-SNS-BAT axis may help treat cachexia and obesity.

Altered hypothalamic activity may contribute to stress in alopecia areata patients.

New treatments for common hair loss are needed.

People with alopecia areata have higher insulin resistance.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Hair loss may indicate higher risk of heart disease.

Latanoprost therapy potentially caused a woman's white hair to darken again.

Generative AI tools like GPT-4o can effectively automate SALT scoring for alopecia areata, matching clinician accuracy.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Mouse high-glycine/tyrosine proteins have distinct patterns in hair follicles, peaking at specific hair cycle days.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Reducing micro-inflammation didn't change hair growth patterns in AGA.

TGF-β1 and 2 may play a role in hair loss in AGA.

Hair loss may increase heart disease risk.

A boy with Oculodentodigital syndrome had a unique GJA1 gene mutation causing his symptoms.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Oral minoxidil helps female hair loss, topical finasteride treats AGA, and sulfotransferase activity predicts minoxidil effectiveness.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Androgens and estrogens are crucial for insulin secretion in males.

SOD1 and KL are promising targets for new hair loss treatments.

Progesterone protects neurons from damage by converting to allopregnanolone, which works through GABAA receptors.

The hydrogel effectively treats hair loss using light to release nitric oxide.

Hair loss may indicate higher heart risk and metabolic issues.

The treatment successfully lowered testosterone levels and reduced symptoms.

Targeting multiple pathways may improve treatments for androgenetic alopecia.